It was found that 20.1% (72 HCC samples) showed genetic alterations, 14% of which occurred in ENFA3, where the main alteration was amplification; 5 mutations occurred in EGF (2.2%) (Figure 8A). The gene discussed is EGF; the disease is hepatocellular carcinoma.